Twitter Facebook LinkedIn

Heat Biologics, Inc. Heat Biologics, Inc.

  • Home
  • About
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Technology
  • Pipeline
    • Overview
    • HS-110
    • HS-130
    • Expanded Access
    • Scientific Publications
  • Investors
  • News & Media
  • Careers
  • Contact

News Releases

Heat Biologics Announces Collaboration with Waisman Biomanufacturing to Manufacture COVID-19 Vaccine

May 27, 2020

Heat Biologics Provides First Quarter 2020 Business Update

May 15, 2020

Positive Survival Data from Phase 2 Lung Cancer Trial Accepted for Presentation at 2020 American Society of Clinical Oncology (ASCO) Annual Meeting

May 14, 2020

Heat Biologics Provides Clinical Update; Reports Continued Progress Advancing HS-110

May 11, 2020

Heat Biologics Reports Progress on COVID-19 Efforts and Timeline of Anticipated Q2 2020 Milestones

Apr 29, 2020

Heat Biologics Announces Formation of COVID-19 Advisory Board

Apr 1, 2020

Heat Biologics Provides Year-End Business Update

Mar 30, 2020

Heat Biologics and University of Miami Developing Proprietary COVID-19 Diagnostic Test Under Collaborative Research Agreement

Mar 23, 2020

Heat Biologics Invited to Join The Alliance for Biosecurity

Mar 16, 2020

Heat Biologics, Inc. to Present at the Spring Investor Summit on March 25th-26th in New York City

Mar 5, 2020
    • 1...
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • ...29
    NightHawk Biosciences

    OUR ECOSYSTEM

    SkunkWorx Bio
    Heat Biologics
    Elusys Therapeutics Inc.
    Pelican Therapeutics
    Scorpion Biological Services
    © 2022 Heat Biologics, Inc. All Rights Reserved.
    Privacy Policy Disclaimer Sitemap LinkedIn